# "Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

> **NCT05495308** · — · COMPLETED · sponsor: **Hospital San Carlos, Madrid** · enrollment: 4 (actual)

## Conditions studied

- Rectal Cancer, Adenocarcinoma
- Rectal Cancer Stage II
- Rectal Cancer Stage III
- Distant Metastasis
- Local Recurrence of Malignant Tumor of Rectum

## Interventions

- **PROCEDURE:** neoadjuvant treatment

## Key facts

- **NCT ID:** NCT05495308
- **Lead sponsor:** Hospital San Carlos, Madrid
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05495308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05495308, ""Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05495308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
